Tactile Systems Technology (TCMD) Capital Expenditures Growth (3y) (2018 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Capex Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | 1.64% |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | 8.49% |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | 10.17% |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | 16.83% |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | 1.81% |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 2.15% |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | 0.84% |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | 10.35% |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | 8.08% |
| 10 | Tactile Systems Technology | 539.21 Mn | 449.02 Mn | 57.61 Mn | 50.47% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 50.47% |
| Dec 31, 2025 | 118.34% |
| Sep 30, 2025 | -7.11% |
| Jun 30, 2025 | 22.65% |
| Mar 31, 2025 | 42.49% |
| Dec 31, 2024 | -19.51% |
| Sep 30, 2024 | 15.41% |
| Jun 30, 2024 | 12.20% |
| Mar 31, 2024 | 24.63% |
| Dec 31, 2023 | 27.33% |
| Sep 30, 2023 | -26.59% |
| Jun 30, 2023 | 38.48% |
| Mar 31, 2023 | -12.36% |
| Dec 31, 2022 | -65.27% |
| Sep 30, 2022 | -17.75% |
| Jun 30, 2022 | -42.07% |
| Mar 31, 2022 | -43.62% |
| Dec 31, 2021 | -21.34% |
| Sep 30, 2021 | -3.33% |
| Jun 30, 2021 | -34.64% |
| Mar 31, 2021 | -16.78% |
| Dec 31, 2020 | -37.58% |
| Sep 30, 2020 | 30.13% |
| Jun 30, 2020 | -28.20% |
| Mar 31, 2020 | -20.03% |
| Dec 31, 2019 | 65.74% |
| Sep 30, 2019 | 130.29% |
| Jun 30, 2019 | 72.63% |
| Mar 31, 2019 | 86.88% |
| Dec 31, 2018 | 119.22% |
| Sep 30, 2018 | 62.64% |